BANK VONTOBEL/CALL/ABBOTT LABORATORIES/95/0.1/21.06.24 Stock

Warrant

DE000VM02XW8

Delayed Deutsche Boerse AG 14:06:01 2024-05-31 EDT
0.66 EUR -4.35% Intraday chart for BANK VONTOBEL/CALL/ABBOTT LABORATORIES/95/0.1/21.06.24
1 month-44.54%
3 months-72.84%
Date Price Change
24-05-31 0.66 -4.35%
24-05-30 0.69 +4.55%
24-05-29 0.66 -4.35%
24-05-28 0.69 -17.86%
24-05-27 0.84 -5.62%

Delayed Quote Deutsche Boerse AG

Last update May 31, 2024 at 02:06 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
IssuerLogo Issuer Vontobel Vontobel
WKN VM02XW
ISINDE000VM02XW8
Date issued 2023-08-09
Strike 95 $
Maturity 2024-06-21 (19 Days)
Parity 10 : 1
Emission price 1.66
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 2.57
Lowest since issue 0.65
Spread 0.01
Spread %1.39%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
102.2 USD
Average target price
125.4 USD
Spread / Average Target
+22.69%
Consensus